Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
TriLink BioTechnologies
TriLink BioTechnologies
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Analysis
The analytics advancements driving mRNA breakthroughs
mRNA therapeutics are attracting attention because they can be manufactured rapidly to treat previously undruggable diseases
Ingredients
TriLink offers new GMP-grade material for mRNA manufacturing
N1-Methyl-Pseudouridine-5’-Triphosphate, a critical raw material for mRNA manufacturing, allows researchers to accelerate their drug discovery and development
Design & Build
TriLink to open GMP facility aimed at early phase therapeutic manufacturing
Plant will be fully operational by July
Design & Build
TriLink BioTechnologies to work with American Cleanroom Systems to build cGMP facility
Will contain nine labs and is scheduled to be completed in the first quarter of 2014
Subscribe now